Appeals Court Reinstates Antitrust Suit Over Taxol Generics
A U.S. appeals court has paved the way for Xechem International to seek treble damages in an antitrust suit against drug maker Bristol-Myers Squibb over its alleged efforts to thwart generic...To view the full article, register now.
Already a subscriber? Click here to view full article